世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2014年
3期
331-332,334
,共3页
乳核散结片%乳癖消%乳腺增生症
乳覈散結片%乳癖消%乳腺增生癥
유핵산결편%유벽소%유선증생증
Ruhesanjie tablets%Rupixiao tablets%Breast hyperplasia
目的：研究乳癖消和乳核散结片对乳腺增生症的治疗作用。方法：采用随机对照前瞻性研究，365名患者分两组，乳癖消片用法为：2.01 g，tid，po，疗程3个月。乳核散结片组用法为4片（1.44 g），tid，po，疗程3个月。两组中治疗无效者进入另一组继续治疗。疗效判定分为四级：临床治愈、显效、有效、无效。停药后跟踪随访半年，观察各个治疗组的疗效。结果：乳癖消片首治者，有效率（临床治愈、显效、有效）为72.22％，无效27.78％；乳核散结片首治者有效率为89.73％，无效10.27％。乳核散结片组的有效率高于乳癖消片组。乳癖消首治无效者服用乳核散结片后有64％的患者有效；而乳核散结片首治无效者服用乳癖消后有57.89％的患者有效。结论：本研究提示乳核散结片是治疗乳腺增生症的一种疗效肯定的较好药物。
目的：研究乳癖消和乳覈散結片對乳腺增生癥的治療作用。方法：採用隨機對照前瞻性研究，365名患者分兩組，乳癖消片用法為：2.01 g，tid，po，療程3箇月。乳覈散結片組用法為4片（1.44 g），tid，po，療程3箇月。兩組中治療無效者進入另一組繼續治療。療效判定分為四級：臨床治愈、顯效、有效、無效。停藥後跟蹤隨訪半年，觀察各箇治療組的療效。結果：乳癖消片首治者，有效率（臨床治愈、顯效、有效）為72.22％，無效27.78％；乳覈散結片首治者有效率為89.73％，無效10.27％。乳覈散結片組的有效率高于乳癖消片組。乳癖消首治無效者服用乳覈散結片後有64％的患者有效；而乳覈散結片首治無效者服用乳癖消後有57.89％的患者有效。結論：本研究提示乳覈散結片是治療乳腺增生癥的一種療效肯定的較好藥物。
목적：연구유벽소화유핵산결편대유선증생증적치료작용。방법：채용수궤대조전첨성연구，365명환자분량조，유벽소편용법위：2.01 g，tid，po，료정3개월。유핵산결편조용법위4편（1.44 g），tid，po，료정3개월。량조중치료무효자진입령일조계속치료。료효판정분위사급：림상치유、현효、유효、무효。정약후근종수방반년，관찰각개치료조적료효。결과：유벽소편수치자，유효솔（림상치유、현효、유효）위72.22％，무효27.78％；유핵산결편수치자유효솔위89.73％，무효10.27％。유핵산결편조적유효솔고우유벽소편조。유벽소수치무효자복용유핵산결편후유64％적환자유효；이유핵산결편수치무효자복용유벽소후유57.89％적환자유효。결론：본연구제시유핵산결편시치료유선증생증적일충료효긍정적교호약물。
Objective:To study the therapeutic effects of Rupixiao tablets and Ruhesanjie tablets to treat breast hyperplasia .Methods:Prospective control randomized control trial was conducted , and 365 patients were divided into two groups .Patients in Rupixiao tablets group were given 2.01g,tid,po, for 3 month and Ruhesanjie tablets group applied 1.44g, tid, po, for 3 month.Patients that are non-re-spond were included into the other group to continue the treatment .The effect was classified to four degrees , including clinical cure , sig-nificantly effective, effective, and ineffective.Follow-up was conducted for half a year .The total effective rates of the two groups were observed.Results:The effective rate (clinical cure, significantly effective, effective) of patients first treated with Rupixiao tablets was 72.22%, and inefficacy rate was 27.78%.The effective rate of Ruhesanjie tablets group was 89.73% and the ineffective rate was 10.27%.Sixty four percent of patients who were not responding to Rupixiao tablets showed effect to Ruhesanjie tablets .While 57.89%of patients had effect with Rupixiao tablets when first treated with Ruhesanjie tablets and showed no effect .Conclusion:Ruhesanjie tab-lets are a good efficacy medicine to treat breast hyperplasia .
